Buprenorphine And Naloxone Sublingual Tablets 1
Buprenorphine Hcl And Naloxone Hcl Tablet
Product Images NDC 63629-7269
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hcl And Naloxone Hcl (NDC 63629-7269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Buprenorphine And Naloxone Sublingual Tablets 2
Buprenorphine And Naloxone Sublingual Tablets 3
Lbl636295074
This appears to be a label of a medication manufactured by Amnzal Pharmazeuteals LLC, with the NDC number 6362950741 0507410000. The medication comes in tablets form, possibly named "Suboione Bmy2ng (CIl) Tatlet", and it needs to be kept in a light-resistant container at room temperature (20-25 C or 68-77F) until the expiration date indicated on the label, which is represented by #30 Exp: MMYY.*
Lbl636297269
This is a label for Suborone SL 205mg tablets with instructions to store the tablets at room temperature of 20°-25°C (68°-77°F). The pack contains 30 tablets, with an expiry date of MMYY and an NDC number of 6362972691 072691138567. There is also a warning to keep all drugs out of children's reach.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
